Form 8-K - Current report:
SEC Accession No. 0001193125-25-033463
Filing Date
2025-02-24
Accepted
2025-02-24 16:30:37
Documents
13
Period of Report
2025-02-20
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d876806d8k.htm   iXBRL 8-K 23997
  Complete submission text file 0001193125-25-033463.txt   142237

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA bmrn-20250220.xsd EX-101.SCH 2853
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE bmrn-20250220_lab.xml EX-101.LAB 17235
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bmrn-20250220_pre.xml EX-101.PRE 10814
16 EXTRACTED XBRL INSTANCE DOCUMENT d876806d8k_htm.xml XML 3576
Mailing Address 105 DIGITAL DRIVE NOVATO CA 94949
Business Address 105 DIGITAL DRIVE NOVATO CA 94949 4155066700
BIOMARIN PHARMACEUTICAL INC (Filer) CIK: 0001048477 (see all company filings)

EIN.: 680397820 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-26727 | Film No.: 25657495
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)